Submitting Advanced Bioanalytical Test Methods for Regulatory Approval - - BioPharm International

ADVERTISEMENT

Submitting Advanced Bioanalytical Test Methods for Regulatory Approval


BioPharm International


References:

1. Krause, SO. Qualifying Release Laboratories in Europe and the United States. BioPharm International 2004; 17 (3):28-36.

2. Krause, SO. Development and validation of analytical methods for biopharmaceuticals, part I: development and optimization. BioPharm International 2004; 17(10):52-61.

3. Krause, SO. Development and validation of analytical methods for biopharmaceuticals, part II: formal validation. BioPharm International 2004; 17(11):46-52.

4. Krause, SO. Analytical Method Validation for Biopharmaceuticals, BioPharm International, A Guide to Validation 2005; 24-32.

5. ICH. Validation of Analytical Procedures. Q2A. Federal Register 1995; 60.

6. ICH. Validation of Analytical Procedures: methodology. Q2B. Federal Register 1996; 62.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here